Abstract
The deuterohemin-peptide conjugate, DhHP-6 (Dh-β-AHTVEK-NH2), is a microperoxidase mimetic, which has demonstrated substantial benefits in vivo as a scavenger of reactive oxygen species (ROS). In this study, specific multi-site N-methylated derivatives of DhHP-6 were designed and synthesized to improve metabolic stability and intestinal absorption, which are important factors for oral delivery of therapeutic peptides and proteins. The DhHP-6 derivatives were tested for (1) scavenging potential of hydrogen peroxide (H2O2); (2) permeability across Caco-2 cell monolayers and everted gut sacs; and (3) enzymatic stability in serum and intestinal homogenate. The results indicated that the activities of the DhHP-6 derivatives were not influenced by N-methylation, and that tri-N-methylation of DhHP-6 could significantly increase intestinal flux, resulting in a two- to threefold higher apparent permeability coefficient. In addition, molecules with N-methylation at selected sites (e.g., Glu residue) showed high resistance against proteolytic degradation in both diluted serum and intestinal preparation, with 50- to 140-fold higher half-life values. These findings suggest that the DhHP-6 derivatives with appropriate N-methylation could retain activity levels equivalent to that of the parent peptide, while showing enhanced intestinal permeability and stability against enzymatic degradation. The tri-N-methylated peptide Dh-β-AH(Me)T(Me)V(Me)EK-NH2 derived from this study may be developed as a promising candidate for oral administration.
Similar content being viewed by others
Abbreviations
- ROS:
-
Reactive oxygen species
- APx:
-
Ascorbate peroxidase
- PEG:
-
Polyethylene glycol
- DMF:
-
N,N-dimethylformamide
- HOBT:
-
1-Hydroxy-1H-benzotriazole
- NMM:
-
N-methylmorpholine
- HATU:
-
O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate
- HOAt:
-
3H-[1,2,3]-triazolo[4,5-b]pyridin-3-ol
- DIEA:
-
N,N-diisopropylethylamine
- NMP:
-
N-methylpyrrolidone
- PyBop:
-
Benzotriazole-1-yl-oxytripyrrolidino-phosphonium hexafluorophosphate
- TFA:
-
Trifluoroacetic acid
- R-CHCA:
-
R-cyano-4-hydroxycinnamic acid
- DMEM:
-
Dulbecco’s Modified Eagle’s Medium
- TEER:
-
Transepithelial electrical resistance
- HBSS:
-
Hank’s balanced salt solution
References
Artursson P, Karlsson J (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175:880–885
Artursson P, Magnusson C (1990) Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. J Pharm Sci 79:595–600
Barthe L, Woodley JF, Kenworthy S, Houin G (1998) An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine. Eur J Drug Metab Pharmacokinet 23:313–323
Barthe L, Woodley JF, Houin G (1999) Gastrointestinal absorption of drugs: methods and studies. Fundam Clin Pharmacol 13:154–168
Berlett BS, Stadtman ER (1997) Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272:20313–20316
Bernkop-Schnürch A, Walker G (2001) Multifunctional matrices for oral peptide delivery. Crit Rev Ther Drug Carrier Syst 18:459–501
Biron E, Chatterjee J, Ovadia O, Langenegger D, Brueggen J, Hoyer D, Schmid HA, Jelinek R, Gilon C, Hoffman A, Kessler H (2008) Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. Angew Chem Int Ed Engl 47:2595–2599
Burton PS, Conradi RA, Hilgers AR, Ho NF (1993) Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. Biochem Biophys Res Commun 190:760–766
Chatterjee PK, Patel NS, Kvale EO, Brown PA, Stewart KN, Mota-Filipe H, Sharpe MA, Di Paola R, Cuzzocrea S, Thiemermann C (2004) EUK-134 reduces renal dysfunction and injury caused by oxidative and nitrosative stress of the kidney. Am J Nephrol 24:165–177
Chatterjee J, Gilon C, Hoffman A, Kessler H (2008) N-methylation of peptides: a new perspective in medicinal chemistry. Acc Chem Res 41:1331–1342
Day BJ (2004) Catalytic antioxidants: a radical approach to new therapeutics. Drug Discov Today 9:557–566
Gan LS, Niederer T, Eads C, Thakker D (1993) Evidence for predominantly paracellular transport of thyrotropin-releasing hormone across Caco-2 cell monolayers. Biochem Biophys Res Commun 197:771–777
Gao JN, Hugger ED, Beck-Westermeyer MS, Borchardt RT (2001) Estimating intestinal mucosal permeation of compounds using Caco-2 cell monolayers. Curr Protoc Pharmacol Chapter 7:Unit 7.2
Gentilucci L, De MR, Cerisoli L (2010) Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des 16:3185–3203
Grunwald J, Rejtar T, Sawant R, Wang Z, Torchilin VP (2009) TAT peptide and its conjugates: proteolytic stability. Bioconjug Chem 20:1531–1537
Guan SW, Li PF, Luo J, Li YY, Huang L, Wang G, Zhu LM, Fan HK, Li W, Wang LP (2010) A deuterohemin peptide extends lifespan and increases stress resistance in Caenorhabditis elegans. Free Radic Res 44:813–820
Hamman JH, Enslin GM, Kotzé AF (2005) Oral delivery of peptide drugs: barriers and developments. BioDrugs 19:165–177
Han HK, Stewart BH, Doherty AM, Cody WL, Amidon GL (1998) In vitro stability and intestinal absorption characteristics of hexapeptide endothelin receptor antagonists. Life Sci 63:1599–1609
Hess S, Ovadia O, Shalev DE, Senderovich H, Qadri B, Yehezkel T, Salitra Y, Sheynis T, Jelinek R, Gilon C, Hoffman A (2007) Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability. J Med Chem 50:6201–6211
Lee HJ (2002) Protein drug oral delivery: the recent progress. Arch Pharm Res 25:572–584
Lennernäs H (1998) Human intestinal permeability. J Pharm Sci 87:403–410
Linde Y, Ovadia O, Safrai E, Xiang Z, Portillo FP, Shalev DE, Haskell-Luevano C, Hoffman A, Gilon C (2008) Structure–activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides. Biopolymers 90:671–682
Lister-James J, Dean RT, Pearson DA, Wilson DM (2001) Novel somatostatin analogs. WO 01/44177 A2
Liu, YL (2003) Peptide mimics of peroxidase with anti-cataract activity. Dissertation, University of Jilin, pp 65–70
Liu YL, Guo LL, Roger R, Luo GM, Li W (2001) The method improvement of synthesis and purification of deuterohemin. Acta Sci Nat Univ Jilin, 91–92
Mahato RI, Narang AS, Thoma L, Miller DD (2003) Emerging trends in oral delivery of peptide and protein drugs. Crit Rev Ther Drug Carrier Syst 20:153–214
Mandelman D, Schwarz FP, Li H, Poulos TL (1998) The role of quaternary interactions on the stability and activity of ascorbate peroxidase. Protein Sci 7:2089–2098
Masini E, Cuzzocrea S, Mazzon E, Marzocca C, Mannaioni PF, Salvemini D (2002) Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo. Br J Pharmacol 136:905–917
Nakabeppu Y, Tsuchimoto D, Yamaguchi H, Sakumi K (2007) Oxidative damage in nucleic acids and Parkinson’s disease. J Neurosci Res 85:919–934
Nestor JJ Jr (2009) The medicinal chemistry of peptides. Curr Med Chem 16:4399–4418
Ovadia O, Greenberg S, Chatterjee J, Laufer B, Opperer F, Kessler H, Gilon C, Hoffman A (2011) The effect of multiple N-methylation on intestinal permeability of cyclic hexapeptides. Mol Pharm 8:479–487
Reed TT (2011) Lipid peroxidation and neurodegenerative disease. Free Radic Biol Med 51:1302–1319
Rice-Evans CA, Diplock AT (1993) Current status of antioxidant therapy. Free Radic Biol Med 15:77–96
Smith KR, Uyeminami DL, Kodavanti UP, Crapo JD, Chang L, Pinkerton KE (2002) Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant. Free Radic Biol Med 33:1106–1114
Takács-Novák K, Avdeef A, Box KJ, Podányi B, Szász G (1994) Determination of protonation macro- and microconstants and octanol/water partition coefficient of the antiinflammatory drug niflumic acid. J Pharm Biomed Anal 12:1369–1377
Wang JY, Zhu SG, Xu CF (2002) Biochemistry, 3rd edn. Higher education press, Beijing, pp 174, 402–405
Wang LP, Liu YL, Yang H, Li W (2004) Synthesis and anti-cataract activity of a novel peroxidase mimetics. Chem J Chin Univ 25:2171–2173
Watson CJ, Rowland M, Warhurs G (2001) Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers. Am J Physiol Cell Physiol 281:C388–C397
Woodley JF (1994) Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst 11:61–95
Acknowledgments
This work was supported by the National Natural Science Foundation of China (No. 30901863, 20872048) and China Postdoctoral Science Foundation (No. 20110491321). We gratefully acknowledge Hui Cai and Xu Yang (Changchun BCHT Co. Ltd.) for their assistance with peptide synthesis.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Q.-G. Dong and Y. Zhang contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Dong, QG., Zhang, Y., Wang, MS. et al. Improvement of enzymatic stability and intestinal permeability of deuterohemin-peptide conjugates by specific multi-site N-methylation. Amino Acids 43, 2431–2441 (2012). https://doi.org/10.1007/s00726-012-1322-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-012-1322-y